-
IntroducedMar 07, 2024
-
Passed Senate
-
Passed House
-
Signed into Law
AN ACT INCREASING THE RATE OF THE CREDIT REFUND VALUE FOR CERTAIN EXPENDITURES BY BIOTECHNOLOGY COMPANIES. To increase the rate of the credit refund value for research and experimental expenditures or research and development expenses of biotechnology companies.
Last Action See all actions
House • Mar 25, 2024: Favorable Change of Reference, House to Committee on Finance, Revenue and Bonding
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on SB 379
Tweets
Whip Lists
Sponsors
- Commerce Committeeprimary
Votes
YES: 24
- Hartley J
- Meskers S
- Rahman M
- Fazzino J
- Martin H
- Harrison C
- Anderson M
- Aniskovich C
- Cheeseman H
- Currey J
- Figueroa A
- Foster J
- Garibay J
- Gee F
- Heffernan W
- Hochadel J
- McGorty B
- Miller P
- Needleman N
- Poulos C
- Rochelle K
- Somers H
- Vail K
- Wood K
NO: 0
OTHER: 0
Actions
- Mar 25, 2024 | House
- Favorable Change of Reference, House to Committee on Finance, Revenue and Bonding
- Mar 25, 2024 | Senate
- Reported Out of Legislative Commissioners' Office (LCO)
- Favorable Change of Reference, Senate to Committee on Finance, Revenue and Bonding
- Mar 22, 2024 | Senate
- Filed with Legislative Commissioners' Office (LCO)
- Mar 21, 2024 | Senate
- Joint Favorable Change of Reference Finance, Revenue and Bonding (CE)
- Mar 08, 2024 | Senate
- Public Hearing 03/14
- Mar 07, 2024 | Senate
- Referred to Joint Committee on Commerce
×
Try FastDemocracy Professional
Try FastDemocracy Professional
Are you part of a non-profit, business, government relations firm or association? We can take your advocacy to the next level!
Report a comment
×
Do you want to add this event to your calendar?